In her most recent blog post, Associate Member Emmaline Fisher discusses patent evergreening, its effects on prescription drug prices, and the USPTO’s and the FDA’s response to President Biden’s Executive Order that this issue be addressed and fixed.
In this article, Associate Member Emmaline Fisher discusses the limitations of the insulin cap passed with the Inflation Reduction Act, and some currently pending legislation in Congress that seeks to address the ever-increasing cost of insulin.
Associate Member Chris Colloton examines the recent decision from a federal court in Texas in Braidwood Management, Inc. v. Becerra. Chris argues that the judge not only misapplied the law, but moreover worked to elevate religious freedom to an untenable level at the expense of the health of millions of Americans.
